top of page

Our Team

We are a multidisciplinary team of world leaders in addiction research. 

For the first time in Australia, a team of expert researchers from pharmacology, neuropsychology, clinical medicine, psychiatry and behavioural psychology have joined to form a world-leading and internationally unique alcohol treatment research program.  

We are leaders in the discovery science of addiction that bring together collaborative networks and support from the Florey Institute, the University of Sydney, Turning Point, Monash University and the University of New South Wales.  

Our multidisciplinary collaboration works to strengthen the links between basic and clinical research to transform the latest scientific discoveries into innovative, effective and individually tailored treatments for alcohol dependence.  

By bringing together world-leading experimental and clinical research, the TREAT alcohol research program is poised to transform alcohol treatments with high-impact outcomes for Australians and the world.  


My name is Alexa Young

Briefly introduce yourself and share something interesting with website visitors. Double click to edit the text.

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

Item List

Professor Paul Haber, AM

Lead investigator for the TREAT alcohol research program

Professor Haber is a physician who specialises in addiction medicine as well as gastroenterology and hepatology. He is the Clinical Director for Drug Health Services for the Sydney Local Health District, and he has been a consultant to the Royal Prince Alfred Hospital since 1998 and to the Pain Management Service since 2018.

Professor Haber is also a Foundation Fellow and past President of the Royal Australasian College of Physicians Chapter of Addiction Medicine, and a conjoint Professor at the University of Sydney. His research has been funded by grants and fellowships from the National Institutes of Health, the National Health and Medical Research Council, the Alcohol Education and Rehabilitation Foundation and the Department of Veterans' Affairs. He has served on numerous state and national policy advisory committees.

He is interested in exploring new treatments for alcohol use disorders and has been working in clinical trials for twenty years.

Read More

Professor Kirsten Morley

Professor Morley is a Professorial Research Fellow at the University of Sydney, and Head of Addiction Treatment Clinical Research Theme at the Edith Collins Centre, Royal Prince Alfred Hospital.

She has completed over 12 face-to-face clinical trials of treatments for substance use disorder and comorbid mental disorders including psychotherapies and pharmacotherapies and has held 3 prestigious fellowships from the NHMRC and NSW Health.

Professor Morley is the lead author of the National Alcohol Treatment Guidelines for Pharmacotherapy and leads a large alcohol clinical trials research program funded by the NHMRC and the Medical Research Future Fund (MRFF).

She leads a team that aims to improve treatments for substance use disorders including comorbid mental disorders to enhance our understanding of the clinical neuroscience of substance use disorders and response to treatment.

Read More

Professor Andrew Lawrence

Professor Lawrence is a Senior Principal Research Fellow and Deputy Director at The Florey where he runs the Addiction Neuroscience Group. His research interests focus on identifying novel therapeutic targets for alcohol and substance use disorders, stemming from basic discovery science through to clinical trials. His research into the motivation to seek and consume alcohol has consistently combined neuroscience and pharmacology to identify circuits, neurotransmitters and novel therapeutic targets.

Professor Lawrence has published over 300 original articles and reviews. He is an Honorary Fellow of the British Pharmacological Society, the Editor-in-Chief of the Journal of Neurochemistry and the Senior Vice-President of the International Society for Biomedical Research on Alcoholism.

In 2017, Professor Lawrence delivered the Lawrie Austin Plenary lecture at the Australasian Neuroscience Society annual meeting and in 2021 gave the opening Plenary lecture at the Japanese Society for Neurochemistry annual conference.

Read More

Professor Victoria Manning

Professor Manning is the Head of Research and Workforce Development at Turning Point, Victoria, Australia, and a Professor of Addiction Studies at Monash University.

She is a research psychologist, a SMART Recovery group facilitator and the founder of the SWiPE Brain Training app. She holds a PhD in neurocognition and co-occurring disorders and has worked as a clinical researcher in addiction treatment in the UK, Asia and Australia for over two decades.

Professor Manning’s research portfolio includes psychological, neurocognitive, pharmacological and peer-based trials. She is a lecturer for the Graduate Program of Addictive Behaviours course at Monash University and PhD supervisor.

Read More

Professor Dan Lubman, AM

Professor Lubman is the Executive Clinical Director, Turning Point, and a Professor of Addiction Studies and Services at Monash University. He has worked across mental health and drug treatment settings in the UK and Australia.

His research is wide-ranging and includes investigating the harms associated with alcohol, drugs and gambling; the impact of alcohol and drug use on brain function; the relationship between substance use, gambling and mental disorder; as well as the development of targeted telephone, online and face-to-face intervention programs within school, primary care, mental health and drug treatment settings.

Professor Lubman has published over 500 major reports, peer-reviewed scientific papers and book chapters, and was Chair of the Royal Australian and New Zealand College of Psychiatrists' Faculty of Addiction Psychiatry for over a decade. He is regularly contacted for policy advice and community comment and sits on numerous government expert committees.

Read More

Professor Gavan McNally

Professor McNally is a Professor of Psychology and Neuroscience at UNSW Sydney where he leads the Behavioural Neuroscience Laboratory – a modern, state-of-the-art research facility that includes Australia’s first facilities for in vivo optogenetics, in vivo calcium imaging, and fibre photometry.

His research has provided new insights into the learning and decision-making mechanisms through which we recognise that our behaviours may be causing us harm, the brain cellular and circuit mechanisms underlying relapse to alcohol-seeking, and the brain cellular and circuit mechanisms for risky decision-making.

Professor McNally is a Fellow of the Academy of Social Sciences in Australia, a Fellow of the Association for Psychological Science, and a Fellow of the American Psychological Association. He is also President-Elect of the European Behavioural Pharmacology Society and has won numerous awards, as well as the QEII and Professorial Fellowships from the Australian Research Council.

Read More

Dr Zayra Millan

Dr Millan’s research program examines how the brain controls alcohol consumption. Her research spans neuropharmacology, cognitive models of decision-making, associative learning, and direct stimulation of brain circuits to curb alcohol consumption. She focuses primarily on the brain’s limbic-striatal system, prefrontal cortex and paraventricular thalamus, and uses preclinical animal models of relapse, abstinence, and decision-making, combined with state-of-the-art optical tools, to probe, image and map critical brain circuits. Currently, she is using computational models and machine learning frameworks to identify clusters of cells that can predict drinking and decision-making.

Dr Millan did a combined Master of Psychology (Clinical) and PhD at the University of New South Wales. During her clinical training, she worked with individuals seeking treatment for alcohol consumption and studied brain circuits of relapse in animal models. She completed postdoctoral training at the University of California San Francisco, then at the Johns Hopkins University, and is now a lecturer at the University of New South Wales.

Her research is currently funded by international and national grants, including the NARSAD Brain and Behavior Research Foundation (Young Investigator Grant) and the NHMRC (through an NHMRC Ideas Grant, and an NHMRC Synergy Grant).

Read More

Associate Professor Shalini Arunogiri

Associate Professor Arunogiri is the Clinical Director, Statewide Centre for Mental Health and Addiction, Turning Point, and a Senior Research Fellow at the Monash Addiction Research Centre.

Following completion of a PhD in methamphetamine-associated psychosis, Associate Professor Arunogiri’s research has focused on innovation in the treatment of co-occurring mental health and addictive disorders, with a recent National Health and Medical Research Council (NHMRC) Investigator Grant on trauma/PTSD and co-occurring addiction.

Her work includes over 50 publications, and over $18M in competitive grant funding, including several clinical trials in novel treatments for addiction. She is a passionate advocate for women in medicine and STEMM fields.

Associate Professor Arunogiri is committed to driving change in the mental health and addiction sector, looking to a future where individuals and families can access care without stigma or fear of judgement.

Read More
bottom of page